Gregory Renza Analyst PerformanceAnalyst at Royal Bank Of CanadaGregory Renza is a stock analyst at Royal Bank Of Canada in the healthcare sector, covering 36 publicly traded companies. Over the past year, Gregory Renza has issued 110 stock ratings, including buy and hold recommendations. While full access to Gregory Renza's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Gregory Renza's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings157 Last 6 YearsBuy Recommendations78.95% 120 Buy RatingsCompanies Covered36 Unique Companies Ratings Distribution152RatingsDistribution of strong buy, buy, hold, and sell ratings by Gregory Renza.RatingPercentageCount Strong Buy0.0%0 ratings Buy78.9%120 ratings Hold21.1%32 ratings Sell0.0%0 ratingsOut of 152 total stock ratings issued by Gregory Renza at Royal Bank Of Canada, the majority (78.9%) have been Buy recommendations, followed by 21.1% Hold.Best & Worst CallsBest Call0000.0%CDTXDec 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AVTXMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ91.7% of companies on NASDAQ33 companiesNYSE5.6% of companies on NYSE2 companiesNYSEAMERICAN2.8% of companies on NYSEAMERICAN1 companyGregory Renza, an analyst at Royal Bank Of Canada, currently covers 36 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare36 companies100.0%Gregory Renza of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY30 companies83.3%PHARMACEUTICALS6 companies16.7% Gregory Renza's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsZYMEZymeworks11/10/2026Boost Price Target$31.33$36.00Buy$0.0000.00% ROIONCBeOne Medicines11/6/2026Reiterated Rating$408.18$448.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/6/2026Lower Price Target$29.16$35.00Buy$0.0000.00% ROIVRDNViridian Therapeutics11/5/2026Boost Price Target$28.94$42.00Buy$0.0000.00% ROIRVMDRevolution Medicines11/5/2026Reiterated Rating$189.60$261.00Buy$0.0000.00% ROIAMGNAmgen11/4/2026Boost Price Target$472.79$398.00Hold$0.0000.00% ROIREGNRegeneron Pharmaceuticals11/2/2026Boost Price Target$966.81$982.00Buy$0.0000.00% ROIEXELExelixis10/30/2026Boost Price Target$71.76$60.00Hold$0.0000.00% ROIGILDGilead Sciences10/30/2026Boost Price Target$172.30$181.00Buy$0.0000.00% ROIGMABGenmab A/S10/29/2026Reiterated Rating$57.32$67.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ZYMEZymeworks10/27/2026Boost Price Target$28.85$35.00Buy$0.0000.00% ROIXNCRXencor10/27/2026Boost Price Target$29.61$40.00Buy$0.0000.00% ROIRVMDRevolution Medicines10/19/2026Boost Price Target$183.06$241.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/13/2026Lower Price Target$22.16$33.00Buy$0.0000.00% ROIVKTXViking Therapeutics10/7/2026Lower Price Target$28.88$85.00Buy$0.0000.00% ROIZYMEZymeworks10/7/2026Boost Price Target$26.71$34.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals10/7/2026Boost Price Target$235.30$286.00Buy$0.0000.00% ROIRVMDRevolution Medicines10/7/2026Boost Price Target$203.00$240.00Buy$0.0000.00% ROIMNKDMannKind10/7/2026Lower Price Target$3.45$5.00Buy$0.0000.00% ROIGILDGilead Sciences10/7/2026Boost Price Target$147.43$158.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/7/2026Boost Price Target$744.46$780.00Buy$0.0000.00% ROIEXELExelixis10/7/2026Boost Price Target$58.44$54.00Hold$0.0000.00% ROIAMGNAmgen10/7/2026Boost Price Target$413.33$380.00Hold$0.0000.00% ROIAGIOAgios Pharmaceuticals10/7/2026Lower Price Target$31.64$37.00Buy$0.0000.00% ROIONCBeOne Medicines10/7/2026Boost Price Target$366.60$420.00Buy$0.0000.00% ROIXNCRXencor9/28/2026Reiterated Rating$24.86$29.00Buy$0.0000.00% ROIABVXAbivax9/22/2026Lower Price Target$102.74$151.00Buy$0.0000.00% ROIRVMDRevolution Medicines8/27/2026Boost Price Target$215.44$239.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals8/26/2026Boost Price Target$258.24$281.00Buy$0.0000.00% ROIRVMDRevolution Medicines8/11/2026Boost Price Target$203.85$231.00Buy$0.0000.00% ROIZYMEZymeworks8/7/2026Boost Price Target$24.68$32.00Buy$0.0000.00% ROIVRDNViridian Therapeutics8/7/2026Boost Price Target$22.87$39.00Buy$0.0000.00% ROICGONCG Oncology8/7/2026Boost Price Target$74.99$85.00Buy$0.0000.00% ROIEXELExelixis8/6/2026Lower Price Target$55.13$52.00Hold$0.0000.00% ROIONCBeOne Medicines8/6/2026Boost Price Target$326.61$418.00Buy$0.0000.00% ROIAMGNAmgen8/5/2026Boost Price Target$390.63$362.00Hold$0.0000.00% ROIIDYAIDEAYA Biosciences8/5/2026Lower Price Target$36.34$59.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals8/4/2026Set Price Target$255.83$264.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals7/31/2026Lower Price Target$32.75$39.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals7/31/2026Boost Price Target$736.75$772.00Buy$0.0000.00% ROIToday's free pick (on me) (Ad)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.Get today's free pick before December 8th.NRIXNurix Therapeutics7/10/2026Boost Price Target$22.43$34.00Buy$0.0000.00% ROIAMGNAmgen7/7/2026Boost Price Target$366.44$340.00Hold$0.0000.00% ROIREGNRegeneron Pharmaceuticals7/7/2026Lower Price Target$649.81$769.00Buy$0.0000.00% ROIZYMEZymeworks7/7/2026Boost Price Target$25.33$31.00Buy$0.0000.00% ROIXNCRXencor7/7/2026Lower Price Target$14.89$27.00Buy$0.0000.00% ROINUVBNuvation Bio7/7/2026Boost Price Target$5.58$13.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals7/7/2026Lower Price Target$244.17$254.00Buy$0.0000.00% ROIIDYAIDEAYA Biosciences7/7/2026Lower Price Target$39.37$63.00Buy$0.0000.00% ROIGILDGilead Sciences7/7/2026Lower Price Target$129.61$156.00Buy$0.0000.00% ROIEXELExelixis7/7/2026Boost Price Target$55.53$56.00Hold$0.0000.00% ROIONCBeOne Medicines7/7/2026Boost Price Target$309.46$416.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals7/7/2026Boost Price Target$37.39$41.00Buy$0.0000.00% ROIABVXAbivax7/2/2026Boost Price Target$132.56$155.00Buy$0.0000.00% ROIVRDNViridian Therapeutics6/30/2026Boost Price Target$18.74$38.00Buy$0.0000.00% ROIRVMDRevolution Medicines6/30/2026Boost Price Target$188.66$210.00Buy$0.0000.00% ROIEXELExelixis6/25/2026Downgrade$52.87$54.00Hold$0.0000.00% ROINUVLNuvalent6/9/2026Downgrade$123.25$124.00Hold$0.0000.00% ROIZYMEZymeworks6/9/2026Set Price Target$23.93$28.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals6/9/2026Set Price Target$232.04$256.00Buy$0.0000.00% ROINUVLNuvalent6/9/2026Downgrade$123.35$124.00Hold$0.0000.00% ROINRIXNurix Therapeutics6/8/2026Boost Price Target$15.64$32.00Buy$0.0000.00% ROIABVXAbivax6/2/2026Lower Price Target$77.42$135.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics6/2/2026Downgrade$6.42$4.00Hold$0.0000.00% ROIRVMDRevolution Medicines5/18/2026Initiated Coverage$145.66$179.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/18/2026Lower Price Target$624.63$778.00Buy$0.0000.00% ROICGONCG Oncology5/14/2026Reiterated Rating$69.15$82.00Buy$0.0000.00% ROICGONCG Oncology5/11/2026Reiterated Rating$70.56$77.00Buy$0.0000.00% ROIGILDGilead Sciences5/8/2026Reiterated Rating$131.22$157.00Buy$0.0000.00% ROIONCBeOne Medicines5/7/2026Reiterated Rating$311.80$413.00Buy$0.0000.00% ROIAMGNAmgen5/1/2026Boost Price Target$328.59$327.00Hold$0.0000.00% ROIAGIOAgios Pharmaceuticals4/30/2026Lower Price Target$28.05$36.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/30/2026Lower Price Target$705.87$796.00Buy$0.0000.00% ROIVRDNViridian Therapeutics4/21/2026Lower Price Target$14.68$33.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals3/31/2026Lower Price Target$766.43$801.00Buy$0.0000.00% ROIONCBeOne Medicines2/27/2026Boost Price Target$318.67$412.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics2/24/2026Set Price Target$8.96$17.00$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$155.91$152.00Buy$0.0000.00% ROICGONCG Oncology2/10/2026Boost Price Target$51.08$75.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/2/2026Lower Price Target$757.62$818.00Buy$0.0000.00% ROINUVBNuvation Bio1/27/2026Set Price Target$5.61$13.00$0.0000.00% ROIGILDGilead Sciences1/27/2026Boost Price Target$140.75$145.00Buy$0.0000.00% ROICGONCG Oncology1/9/2026Boost Price Target$54.23$66.00Buy$0.0000.00% ROIAMGNAmgen1/8/2026Boost Price Target$335.74$319.00Hold$0.0000.00% ROIVRDNViridian Therapeutics1/8/2026Lower Price Target$30.45$40.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals1/8/2026Boost Price Target$814.10$820.00Buy$0.0000.00% ROIIDYAIDEAYA Biosciences1/6/2026Boost Price Target$34.94$60.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals12/24/2025Boost Price Target$29.05$38.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics12/11/2025Boost Price Target$13.00$18.00Buy$0.0000.00% ROIADCTADC Therapeutics12/3/2025Reiterated Rating$3.51$5.00Outperform$0.0000.00% ROICGONCG Oncology11/24/2025Set Price Target$42.44$62.00$0.0000.00% ROII'm handing you this one free (Ad)Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.See today's free stock pick before the December 8th deadline hereBCYCBicycle Therapeutics11/24/2025Initiated Coverage$6.32$10.00Hold$0.0000.00% ROIAAPGAscentage Pharma Group International11/24/2025Set Price Target$30.64$51.00$0.0000.00% ROIABVXAbivax11/24/2025Set Price Target$119.12$140.00$0.0000.00% ROIXNCRXencor11/24/2025Initiated Coverage$15.87$29.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics11/24/2025Initiated Coverage$6.32$19.00Hold$0.0000.00% ROINRIXNurix Therapeutics11/24/2025Initiated Coverage$17.37$30.00Buy$0.0000.00% ROICATXPerspective Therapeutics11/24/2025Initiated Coverage$2.17$12.00Buy$0.0000.00% ROIAMGNAmgen11/24/2025Initiated Coverage$337.84$318.00Hold$0.0000.00% ROIXNCRXencor11/24/2025Initiated Coverage$15.87$29.00Buy$0.0000.00% ROIVRDNViridian Therapeutics11/24/2025Initiated Coverage$30.34$41.00Buy$0.0000.00% ROIONCBeOne Medicines11/24/2025Initiated Coverage$347.72$400.00Buy$0.0000.00% ROINUVLNuvalent11/24/2025Initiated Coverage$105.88$140.00Buy$0.0000.00% ROINUVBNuvation Bio11/24/2025Initiated Coverage$7.01$11.00Buy$0.0000.00% ROIMNKDMannKind11/24/2025Initiated Coverage$5.03$9.00Buy$0.0000.00% ROIIDYAIDEAYA Biosciences11/24/2025Initiated Coverage$33.99$59.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics11/24/2025Initiated Coverage$11.29$14.00Buy$0.0000.00% ROICGONCG Oncology11/24/2025Initiated Coverage$42.44$62.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/24/2025Initiated Coverage$25.24$32.00Buy$0.0000.00% ROIABVXAbivax11/24/2025Initiated Coverage$119.12$140.00Buy$0.0000.00% ROIAAPGAscentage Pharma Group International11/24/2025Initiated Coverage$30.64$51.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/22/2025Reiterated Rating$10.63$29.00Outperform$00.0000.00% ROICRMDCorMedix10/21/2025Reiterated Rating$12.16$22.00Outperform$0.0000.00% ROIJSPRJasper Therapeutics7/8/2025Downgrade$91.20$150.00Sector Perform$00.0000.00% ROIEXELExelixis7/8/2025Reiterated Rating$43.67$50.00Sector Perform$00.0000.00% ROIONCBeOne Medicines6/27/2025Upgrade$254.49$311.00Moderate Buy$000.0000.00% ROICDTXCidara Therapeutics5/23/2025Reiterated Rating$25.40$35.00Outperform$0.0000.00% ROIACADACADIA Pharmaceuticals5/19/2025Reiterated Rating$22.01$26.00Outperform$00.0000.00% ROIADCTADC Therapeutics5/15/2025Reiterated Rating$1.81$8.00Outperform$0.0000.00% ROIINOInovio Pharmaceuticals5/14/2025Reiterated Rating$1.86$5.00Sector Perform$0.0000.00% ROIEXELExelixis5/14/2025Reiterated Rating$43.58$40.00Outperform$00.0000.00% ROIONCBeOne Medicines5/8/2025Lower Price Target$236.32$311.00Outperform$000.0000.00% ROIJAZZJazz Pharmaceuticals5/7/2025Lower Price Target$102.22$172.00Outperform$000.0000.00% ROIBCYCBicycle Therapeutics5/2/2025Lower Price Target$9.43$32.00Outperform$0.0000.00% ROIAMGNAmgen5/2/2025Lower Price Target$279.88$320.00Outperform$000.0000.00% ROICGONCG Oncology4/29/2025Boost Price Target$27.91$68.00Outperform$00.0000.00% ROIONCBeOne Medicines4/28/2025Reiterated Rating$249.85$312.00Outperform$000.0000.00% ROISPRBSpruce Biosciences4/16/2025Lower Price Target$9.62$37.50Sector Perform$00.0000.00% ROIONCBeOne Medicines4/7/2025Initiated Coverage$238.51$312.00Outperform$000.0000.00% ROIONCBeOne Medicines4/7/2025Upgrade$220.54$312.00Moderate Buy$000.0000.00% ROICATXPerspective Therapeutics3/27/2025Lower Price Target$2.36$15.00Outperform$0.0000.00% ROICRMDCorMedix3/26/2025Reiterated Rating$7.15$12.00Outperform$0.0000.00% ROIVSTMVerastem3/21/2025Lower Price Target$6.69$14.00Outperform$0.0000.00% ROIINOInovio Pharmaceuticals3/19/2025Lower Price Target$2.03$5.00Sector Perform$0.0000.00% ROIEXELExelixis3/13/2025Boost Price Target$36.92$40.00Outperform$00.0000.00% ROIJAZZJazz Pharmaceuticals2/26/2025Lower Price Target$146.23$178.00Outperform$000.0000.00% ROINRIXNurix Therapeutics1/29/2025Boost Price Target$20.07$27.00Outperform$00.0000.00% ROIAMGNAmgen1/24/2025Reiterated Rating$275.63$324.00Outperform$000.0000.00% ROIIDYAIDEAYA Biosciences1/15/2025Reiterated Rating$23.64$61.00Outperform$00.0000.00% ROICATXPerspective Therapeutics1/14/2025Reiterated Rating$3.22$16.00Outperform$0.0000.00% ROIPCRXPacira BioSciences1/14/2025Reiterated Rating$20.83$18.00Sector Perform$00.0000.00% ROIYour free book is about to disappear (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesMNKDMannKind12/19/2024Upgrade$5.94$10.00Outperform$0.0000.00% ROICDTXCidara Therapeutics12/13/2024Initiated Coverage$21.64$34.00Outperform$000.0000.00% ROICGONCG Oncology12/6/2024Reiterated Rating$33.56$66.00Outperform$00.0000.00% ROIFULCFulcrum Therapeutics11/14/2024Reiterated Rating$3.36$4.00Sector Perform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
